Chimeric CCL2 and CCL8 Peptides Show Antitumor Activity in Breast Cancer
Chimeric peptides combining CCL2 and CCL8 with diphtheria toxin demonstrate effective antitumor activity against human breast tumors.
Asset / Drug
Drug and asset intelligence for Chimeric with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.